![]() ![]() To optimize dose accuracy using ENFit LDT syringes, users should: Recommendations for Health Care Providers, Patients, and Caregivers The FDA is providing recommendations for patients and health care providers to promote the safe use of ENFit LDT syringes, including steps users can take to optimize dose accuracy. The moat area is unique to the design of the ENFit LDT syringes. The FDA is aware of the potential for overdose if the user does not clear the moat area around the tip of the ENFit LDT syringe before administering a medication. ![]() Food and Drug Administration (FDA) is informing patients and health care providers about the potential for overdose, under certain clinical use conditions, when using ENFit low dose tip (LDT) syringes. ![]() The FDA believes that dose accuracy using ENFit LDT syringes can be optimized when users follow the recommendations provided below. Study results showed dosing errors are possible for both traditional syringes and the ENFit LDT syringes, depending on the filling and administration methods used. In the study, a research team at the FDA assessed the risk of medication overdose from the moat area of ENFit LDT syringes by using computer-aided modeling to analyze the maximum possible dosing errors in 0.5 mL and 1.0 mL ENFit LDT syringes and traditional syringes under various clinical use conditions, including varied filling and administration methods. The following article was published in the Journal of Clinical Pharmacy and Therapeutics: Assessing Dosing Errors in Legacy and Low Dose Tip ENFit Syringes. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |